Survival increases in early stage breast cancer after treatment with herceptin and chemo, study finds
Wednesday, October 5, 2011 - 20:30
in Health & Medicine
Treating women with early stage breast cancer with a combination of chemotherapy and the molecularly targeted drug Herceptin significantly increases survival in patients with a specific genetic mutation that results in very aggressive disease, a new study finds.